anti-HIV immune serum globulin (NIAID)

N/A

Report date: 2026/02/02 16:49:49

Base Information

Drug Nameanti-HIV immune serum globulin (NIAID)
Drug Alias NameN/A
ClassificationBiologics > Blood components
Mechanisms of ActionImmunoglobulin replacements
TargetsImmunoglobulin
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto Rico
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A